Understanding Osteoporosis Medications (cont.)
Selective Estrogen Receptor Modulators
Raloxifene (Evista) is a selective estrogen receptor modulator (SERM). Unlike estrogen, the SERM raloxifene is not associated with an increased risk of uterine cancer and reduces invasive breast cancer.
- How SERMs work: SERMs have been specifically tailored to provide the particular estrogen effects. Raloxifene is a SERM that preserves bone density but is not associated with estrogen risk factors such as uterine or breast cancer.
- Who should not use these medications: Persons with the following conditions should not use SERMS:
- Allergy to SERMs
- Active or past history of venous thrombosis (blood clots in veins)
- Use: SERMS are taken orally as a tablet every day for prevention or treatment of osteoporosis.
- Drug or food interactions: Cholestyramine (Questran, Cholybar) decreases raloxifene blood concentrations. The time of administration of each drug should be as far apart as possible.
- Side effects: These drugs may cause hot flushes and blood clots at a risk comparable to that of estrogen. Raloxifene should be discontinued 3 days before surgery and throughout the recovery period following surgery. Call your doctor immediately if you experience any of the following side effects:
- Chest pain
- Trouble breathing
- Coughing up blood
- Pain, swelling, or redness in your leg, particularly if below the knee
- Severe headache
- Blurred vision or vision changes
Medically Reviewed by a Doctor on 2/11/2016
Francisco Talavera, PharmD, PhD
Must Read Articles Related to Understanding Osteoporosis Medications
Hormone Replacement and Osteoporosis
Hormone replacement therapy (HRT) and estrogen replacement therapy (ERT) is often used in treating the learn more >>
Osteoporosis (or porous bone) is a disease in which bone loss occurs, so bones become weak and are more likely to break. This FAQ includes information about tre...learn more >>
Patient Comments & Reviews
The eMedicineHealth doctors ask about Osteoporosis Medications: